Other Species / Isoforms
  SF3B1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K6-ub
__MAKIAkTHEDIEA
0 2
SF3B1 (human) __MAKIAkTHEDIEA K6-ub
SF3B1 (mouse) __MAKIAKtHEDIEA K6
SF3B1 (rat) __MAKIAKTHEDIEA K6
SF3B1 (cow) __MAKIAKTHEDIEA K6
T7
_MAKIAkTHEDIEAQ
0 1
SF3B1 (human) _MAKIAkTHEDIEAQ T7
SF3B1 (mouse) _MAKIAKtHEDIEAQ T7-p
SF3B1 (rat) _MAKIAKTHEDIEAQ T7
SF3B1 (cow) _MAKIAKTHEDIEAQ T7
K21-ub
QIREIQGkkAALDEA
0 1
SF3B1 (human) QIREIQGkkAALDEA K21-ub
SF3B1 (mouse) QIREIQGKKAALDEA K21
SF3B1 (rat) QIREIQGKKAALDEA K21
SF3B1 (cow) QIREIQGKKAALDEA K21
K22-ub
IREIQGkkAALDEAQ
0 1
SF3B1 (human) IREIQGkkAALDEAQ K22-ub
SF3B1 (mouse) IREIQGKKAALDEAQ K22
SF3B1 (rat) IREIQGKKAALDEAQ K22
SF3B1 (cow) IREIQGKKAALDEAQ K22
T36-p
QGVGLDStGyyDQEI
0 1
SF3B1 (human) QGVGLDStGyyDQEI T36-p
SF3B1 (mouse) QGVGLDSTGYYDQEI T36
SF3B1 (rat) QGVGLDSTGYYDQEI T36
SF3B1 (cow) QGVGLDSTGYYDQEI T36
Y38-p
VGLDStGyyDQEIyG
0 4
SF3B1 (human) VGLDStGyyDQEIyG Y38-p
SF3B1 (mouse) VGLDSTGYYDQEIYG Y38
SF3B1 (rat) VGLDSTGYYDQEIYG Y38
SF3B1 (cow) VGLDSTGYYDQEIYG Y38
Y39-p
GLDStGyyDQEIyGG
0 10
SF3B1 (human) GLDStGyyDQEIyGG Y39-p
SF3B1 (mouse) GLDSTGYYDQEIYGG Y39
SF3B1 (rat) GLDSTGYYDQEIYGG Y39
SF3B1 (cow) GLDSTGYYDQEIYGG Y39
Y44-p
GyyDQEIyGGsDSRF
0 19
SF3B1 (human) GyyDQEIyGGsDSRF Y44-p
SF3B1 (mouse) GYYDQEIYGGSDSRF Y44
SF3B1 (rat) GYYDQEIYGGSDSRF Y44
SF3B1 (cow) GYYDQEIYGGSDSRF Y44
S47-p
DQEIyGGsDSRFAGY
0 1
SF3B1 (human) DQEIyGGsDSRFAGY S47-p
SF3B1 (mouse) DQEIYGGSDSRFAGY S47
SF3B1 (rat) DQEIYGGSDSRFAGY S47
SF3B1 (cow) DQEIYGGSDSRFAGY S47
T61-p
YVTSIAAtELEDDDD
0 1
SF3B1 (human) YVTSIAAtELEDDDD T61-p
SF3B1 (mouse) YVTSIAATELEDDDD T61
SF3B1 (rat) YVTSIAATELEDDDD T61
SF3B1 (cow) YVTSIAATELEDDDD T61
Y70-p
LEDDDDDySssTsLL
0 70
SF3B1 (human) LEDDDDDySssTsLL Y70-p
SF3B1 (mouse) LEDDDDDySSSTSLL Y70-p
SF3B1 (rat) LEDDDDDYSSSTSLL Y70
SF3B1 (cow) LEDDDDDYSSSTSLL Y70
S72-p
DDDDDySssTsLLGQ
0 1
SF3B1 (human) DDDDDySssTsLLGQ S72-p
SF3B1 (mouse) DDDDDySSSTSLLGQ S72
SF3B1 (rat) DDDDDYSSSTSLLGQ S72
SF3B1 (cow) DDDDDYSSSTSLLGQ S72
S73-p
DDDDySssTsLLGQK
0 2
SF3B1 (human) DDDDySssTsLLGQK S73-p
SF3B1 (mouse) DDDDySSSTSLLGQK S73
SF3B1 (rat) DDDDYSSSTSLLGQK S73
SF3B1 (cow) DDDDYSSSTSLLGQK S73
S75-p
DDySssTsLLGQKkP
0 1
SF3B1 (human) DDySssTsLLGQKkP S75-p
SF3B1 (mouse) DDySSSTSLLGQKKP S75
SF3B1 (rat) DDYSSSTSLLGQKKP S75
SF3B1 (cow) DDYSSSTSLLGQKKP S75
K81-ub
TsLLGQKkPGyHAPV
0 2
SF3B1 (human) TsLLGQKkPGyHAPV K81-ub
SF3B1 (mouse) TSLLGQKKPGYHAPV K81
SF3B1 (rat) TSLLGQKKPGYHAPV K81
SF3B1 (cow) TSLLGQKKPGYHAPV K81
Y84-p
LGQKkPGyHAPVALL
0 7
SF3B1 (human) LGQKkPGyHAPVALL Y84-p
SF3B1 (mouse) LGQKKPGYHAPVALL Y84
SF3B1 (rat) LGQKKPGYHAPVALL Y84
SF3B1 (cow) LGQKKPGYHAPVALL Y84
Y101-p
IPQSTEQyDPFAEHR
0 1
SF3B1 (human) IPQSTEQyDPFAEHR Y101-p
SF3B1 (mouse) IPQSTEQYDPFAEHR Y101
SF3B1 (rat) IPQSTEQYDPFAEHR Y101
SF3B1 (cow) IPQSTEQYDPFAEHR Y101
Y119-p
IADREDEykKHRRtM
0 10
SF3B1 (human) IADREDEykKHRRtM Y119-p
SF3B1 (mouse) IADREDEYKKHRRtM Y119
SF3B1 (rat) IADREDEYKKHRRTM Y119
SF3B1 (cow) IADREDEYKKHRRTM Y119
K120-ac
ADREDEykKHRRtMI
0 1
SF3B1 (human) ADREDEykKHRRtMI K120-ac
SF3B1 (mouse) ADREDEYKKHRRtMI K120
SF3B1 (rat) ADREDEYKKHRRTMI K120
SF3B1 (cow) ADREDEYKKHRRTMI K120
T125-p
EykKHRRtMIIsPER
Upstream
0 17
Treatment
  • ischemia
SF3B1 (human) EykKHRRtMIIsPER T125-p
SF3B1 (mouse) EYKKHRRtMIIsPER T125-p
SF3B1 (rat) EYKKHRRTMIIsPER T125
SF3B1 (cow) EYKKHRRTMIISPER T125
S129-p
HRRtMIIsPERLDPF
Upstream
0 66
Treatment
  • ischemia
  • LRRK2-IN-1
  • nocodazole
SF3B1 (human) HRRtMIIsPERLDPF S129-p
SF3B1 (mouse) HRRtMIIsPERLDPF S129-p
SF3B1 (rat) HRRTMIIsPERLDPF S129-p
SF3B1 (cow) HRRTMIISPERLDPF S129
K141-ac
DPFADGGktPDPkMN
0 4
SF3B1 (human) DPFADGGktPDPkMN K141-ac
SF3B1 (mouse) DPFADGGKtPDPKMN K141
SF3B1 (rat) DPFADGGktPDPKMN K141-ac
SF3B1 (cow) DPFADGGKTPDPKMN K141
K141-ub
DPFADGGktPDPkMN
0 1
SF3B1 (human) DPFADGGktPDPkMN K141-ub
SF3B1 (mouse) DPFADGGKtPDPKMN K141
SF3B1 (rat) DPFADGGKtPDPKMN K141
SF3B1 (cow) DPFADGGKTPDPKMN K141
T142-p
PFADGGktPDPkMNA
Upstream
1 63
Kinase, in vitro:
  • CDK2 (human)
Treatment
  • dasatinib
  • ischemia
  • LRRK2-IN-1
  • metastatic potential
SF3B1 (human) PFADGGktPDPkMNA T142-p
SF3B1 (mouse) PFADGGKtPDPKMNA T142-p
SF3B1 (rat) PFADGGktPDPKMNA T142-p
SF3B1 (cow) PFADGGKTPDPKMNA T142
K146-ub
GGktPDPkMNARTyM
0 1
SF3B1 (human) GGktPDPkMNARTyM K146-ub
SF3B1 (mouse) GGKtPDPKMNARTYM K146
SF3B1 (rat) GGktPDPKMNARTYM K146
SF3B1 (cow) GGKTPDPKMNARTYM K146
Y152-p
PkMNARTyMDVMREQ
0 14
SF3B1 (human) PkMNARTyMDVMREQ Y152-p
SF3B1 (mouse) PKMNARTYMDVMREQ Y152
SF3B1 (rat) PKMNARTYMDVMREQ Y152
SF3B1 (cow) PKMNARTYMDVMREQ Y152
K175-ub
IRQQLAEkAkAGELk
0 1
SF3B1 (human) IRQQLAEkAkAGELk K175-ub
SF3B1 (mouse) IRQQLAEKAKAGELK K175
SF3B1 (rat) IRQQLAEKAKAGELK K175
SF3B1 (cow) IRQQLAEKAKAGELK K175
K177-m1
QQLAEkAkAGELkVV
0 1
SF3B1 (human) QQLAEkAkAGELkVV K177-m1
SF3B1 (mouse) QQLAEKAKAGELKVV K177
SF3B1 (rat) QQLAEKAKAGELKVV K177
SF3B1 (cow) QQLAEKAKAGELKVV K177
K182-ub
kAkAGELkVVNGAAA
0 1
SF3B1 (human) kAkAGELkVVNGAAA K182-ub
SF3B1 (mouse) KAKAGELKVVNGAAA K182
SF3B1 (rat) KAKAGELKVVNGAAA K182
SF3B1 (cow) KAKAGELKVVNGAAA K182
S190-p
VVNGAAAsQPPskRK
0 7
SF3B1 (human) VVNGAAAsQPPskRK S190-p
SF3B1 (mouse) VVNGAAAsQPPsKRK S190-p
SF3B1 (rat) VVNGAAASQPPsKRK S190
SF3B1 (cow) VVNGAAASQPPSKRK S190
S194-p
AAAsQPPskRKRRWD
Upstream
0 35
Treatment
  • EGF
  • nocodazole
SF3B1 (human) AAAsQPPskRKRRWD S194-p
SF3B1 (mouse) AAAsQPPsKRKRRWD S194-p
SF3B1 (rat) AAASQPPsKRKRRWD S194-p
SF3B1 (cow) AAASQPPSKRKRRWD S194
K195-ac
AAsQPPskRKRRWDQ
0 10
SF3B1 (human) AAsQPPskRKRRWDQ K195-ac
SF3B1 (mouse) AAsQPPsKRKRRWDQ K195
SF3B1 (rat) AASQPPsKRKRRWDQ K195
SF3B1 (cow) AASQPPSKRKRRWDQ K195
K195-ub
AAsQPPskRKRRWDQ
0 3
SF3B1 (human) AAsQPPskRKRRWDQ K195-ub
SF3B1 (mouse) AAsQPPsKRKRRWDQ K195
SF3B1 (rat) AASQPPsKRKRRWDQ K195
SF3B1 (cow) AASQPPSKRKRRWDQ K195
K195-m1
AAsQPPskRKRRWDQ
0 1
SF3B1 (human) AAsQPPskRKRRWDQ K195-m1
SF3B1 (mouse) AAsQPPsKRKRRWDQ K195
SF3B1 (rat) AASQPPsKRKRRWDQ K195
SF3B1 (cow) AASQPPSKRKRRWDQ K195
T203-p
RKRRWDQtADQtPGA
Upstream
0 7
Treatment
  • nocodazole
SF3B1 (human) RKRRWDQtADQtPGA T203-p
SF3B1 (mouse) RKRRWDQtADQtPGA T203-p
SF3B1 (rat) RKRRWDQTADQtPGA T203
SF3B1 (cow) RKRRWDQTADQTPGA T203
T207-p
WDQtADQtPGAtPkk
Upstream
0 95
Treatment
  • BI_4834
  • nocodazole
SF3B1 (human) WDQtADQtPGAtPkk T207-p
SF3B1 (mouse) WDQtADQtPGAtPKk T207-p
SF3B1 (rat) WDQTADQtPGAtPKK T207-p
SF3B1 (cow) WDQTADQTPGAtPKK T207
T211-p
ADQtPGAtPkkLssW
Upstream
1 118
Kinase, in vitro:
  • CDK2 (human)
Treatment
  • BI_4834
  • ischemia
  • nocodazole
SF3B1 (human) ADQtPGAtPkkLssW T211-p
SF3B1 (mouse) ADQtPGAtPKkLssW T211-p
SF3B1 (rat) ADQtPGAtPKKLSSW T211-p
SF3B1 (cow) ADQTPGAtPKKLSSW T211-p
K213-ub
QtPGAtPkkLssWDQ
0 1
SF3B1 (human) QtPGAtPkkLssWDQ K213-ub
SF3B1 (mouse) QtPGAtPKkLssWDQ K213
SF3B1 (rat) QtPGAtPKKLSSWDQ K213
SF3B1 (cow) QTPGAtPKKLSSWDQ K213
K214-ac
tPGAtPkkLssWDQA
0 2
SF3B1 (human) tPGAtPkkLssWDQA K214-ac
SF3B1 (mouse) tPGAtPKKLssWDQA K214
SF3B1 (rat) tPGAtPKKLSSWDQA K214
SF3B1 (cow) TPGAtPKKLSSWDQA K214
K214-ub
tPGAtPkkLssWDQA
0 3
SF3B1 (human) tPGAtPkkLssWDQA K214-ub
SF3B1 (mouse) tPGAtPKkLssWDQA K214-ub
SF3B1 (rat) tPGAtPKKLSSWDQA K214
SF3B1 (cow) TPGAtPKKLSSWDQA K214
K214-sm
tPGAtPkkLssWDQA
0 1
SF3B1 (human) tPGAtPkkLssWDQA K214-sm
SF3B1 (mouse) tPGAtPKKLssWDQA K214
SF3B1 (rat) tPGAtPKKLSSWDQA K214
SF3B1 (cow) TPGAtPKKLSSWDQA K214
S216-p
GAtPkkLssWDQAEt
0 5
SF3B1 (human) GAtPkkLssWDQAEt S216-p
SF3B1 (mouse) GAtPKkLssWDQAEt S216-p
SF3B1 (rat) GAtPKKLSSWDQAEt S216
SF3B1 (cow) GAtPKKLSSWDQAET S216
S217-p
AtPkkLssWDQAEtP
0 7
SF3B1 (human) AtPkkLssWDQAEtP S217-p
SF3B1 (mouse) AtPKkLssWDQAEtP S217-p
SF3B1 (rat) AtPKKLSSWDQAEtP S217
SF3B1 (cow) AtPKKLSSWDQAETP S217
T223-p
ssWDQAEtPGHtPsL
Upstream
0 196
Treatment
  • BI_4834
  • nocodazole
SF3B1 (human) ssWDQAEtPGHtPsL T223-p
SF3B1 (mouse) ssWDQAEtPGHtPsL T223-p
SF3B1 (rat) SSWDQAEtPGHtPSL T223-p
SF3B1 (cow) SSWDQAETPGHTPSL T223
T227-p
QAEtPGHtPsLrWDE
Upstream
0 192
Treatment
  • BI_4834
  • EGF
SF3B1 (human) QAEtPGHtPsLrWDE T227-p
SF3B1 (mouse) QAEtPGHtPsLRWDE T227-p
SF3B1 (rat) QAEtPGHtPSLRWDE T227-p
SF3B1 (cow) QAETPGHTPSLRWDE T227
S229-p
EtPGHtPsLrWDEtP
Upstream
0 67
Treatment
  • nocodazole
SF3B1 (human) EtPGHtPsLrWDEtP S229-p
SF3B1 (mouse) EtPGHtPsLRWDEtP S229-p
SF3B1 (rat) EtPGHtPSLRWDEtP S229
SF3B1 (cow) ETPGHTPSLRWDETP S229
R231-m1
PGHtPsLrWDEtPGR
0 1
SF3B1 (human) PGHtPsLrWDEtPGR R231-m1
SF3B1 (mouse) PGHtPsLRWDEtPGR R231
SF3B1 (rat) PGHtPSLRWDEtPGR R231
SF3B1 (cow) PGHTPSLRWDETPGR R231
T235-p
PsLrWDEtPGRAkGs
0 95
SF3B1 (human) PsLrWDEtPGRAkGs T235-p
SF3B1 (mouse) PsLRWDEtPGRAKGs T235-p
SF3B1 (rat) PSLRWDEtPGRAKGS T235-p
SF3B1 (cow) PSLRWDETPGRAKGS T235
K240-ub
DEtPGRAkGsEtPGA
0 1
SF3B1 (human) DEtPGRAkGsEtPGA K240-ub
SF3B1 (mouse) DEtPGRAKGsEtPGA K240
SF3B1 (rat) DEtPGRAKGSEtPGA K240
SF3B1 (cow) DETPGRAKGSETPGA K240
K240-m1
DEtPGRAkGsEtPGA
0 2
SF3B1 (human) DEtPGRAkGsEtPGA K240-m1
SF3B1 (mouse) DEtPGRAKGsEtPGA K240
SF3B1 (rat) DEtPGRAKGSEtPGA K240
SF3B1 (cow) DETPGRAKGSETPGA K240
S242-p
tPGRAkGsEtPGAtP
0 5
SF3B1 (human) tPGRAkGsEtPGAtP S242-p
SF3B1 (mouse) tPGRAKGsEtPGAtP S242-p
SF3B1 (rat) tPGRAKGSEtPGAtP S242
SF3B1 (cow) TPGRAKGSETPGATP S242
T244-p
GRAkGsEtPGAtPGs
Upstream
Downstream
1 40
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CDK2 (human)
SF3B1 (human) GRAkGsEtPGAtPGs T244-p
SF3B1 (mouse) GRAKGsEtPGAtPGs T244-p
SF3B1 (rat) GRAKGSEtPGAtPGS T244-p
SF3B1 (cow) GRAKGSETPGATPGS T244
T248-p
GsEtPGAtPGsKIWD
Upstream
Downstream
1 35
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CDK2 (human)
SF3B1 (human) GsEtPGAtPGsKIWD T248-p
SF3B1 (mouse) GsEtPGAtPGsKIWD T248-p
SF3B1 (rat) GSEtPGAtPGSKIWD T248-p
SF3B1 (cow) GSETPGATPGSKIWD T248
S251-p
tPGAtPGsKIWDPtP
0 4
SF3B1 (human) tPGAtPGsKIWDPtP S251-p
SF3B1 (mouse) tPGAtPGsKIWDPtP S251-p
SF3B1 (rat) tPGAtPGSKIWDPTP S251
SF3B1 (cow) TPGATPGSKIWDPTP S251
T257-p
GsKIWDPtPsHtPAG
0 36
SF3B1 (human) GsKIWDPtPsHtPAG T257-p
SF3B1 (mouse) GsKIWDPtPsHtPAG T257-p
SF3B1 (rat) GSKIWDPTPSHTPAG T257
SF3B1 (cow) GSKIWDPTPSHTPAG T257
S259-p
KIWDPtPsHtPAGAA
0 23
SF3B1 (human) KIWDPtPsHtPAGAA S259-p
SF3B1 (mouse) KIWDPtPsHtPAGAA S259-p
SF3B1 (rat) KIWDPTPSHTPAGAA S259
SF3B1 (cow) KIWDPTPSHTPAGAA S259
T261-p
WDPtPsHtPAGAAtP
Upstream
0 40
Treatment
  • dasatinib
SF3B1 (human) WDPtPsHtPAGAAtP T261-p
SF3B1 (mouse) WDPtPsHtPAGAAtP T261-p
SF3B1 (rat) WDPTPSHTPAGAATP T261
SF3B1 (cow) WDPTPSHTPAGAATP T261
T267-p
HtPAGAAtPGRGDtP
Upstream
0 129
Treatment
  • dasatinib
  • ischemia
SF3B1 (human) HtPAGAAtPGRGDtP T267-p
SF3B1 (mouse) HtPAGAAtPGRGDtP T267-p
SF3B1 (rat) HTPAGAATPGRGDTP T267
SF3B1 (cow) HTPAGAATPGRGDTP T267
T273-p
AtPGRGDtPGHAtPG
Upstream
1 136
Kinase, in vitro:
  • DYRK1A (human)
Treatment
  • ischemia
  • MG132_withdrawal
SF3B1 (human) AtPGRGDtPGHAtPG T273-p
SF3B1 (mouse) AtPGRGDtPGHAtPG T273-p
SF3B1 (rat) ATPGRGDTPGHATPG T273
SF3B1 (cow) ATPGRGDTPGHATPG T273
T278-p
GDtPGHAtPGHGGAt
0 123
SF3B1 (human) GDtPGHAtPGHGGAt T278-p
SF3B1 (mouse) GDtPGHAtPGHGGAt T278-p
SF3B1 (rat) GDTPGHATPGHGGAT T278
SF3B1 (cow) GDTPGHATPGHGGAT T278
T285-p
tPGHGGAtssARKNR
0 9
SF3B1 (human) tPGHGGAtssARKNR T285-p
SF3B1 (mouse) tPGHGGAtssARKNR T285-p
SF3B1 (rat) TPGHGGATSSARKNR T285
SF3B1 (cow) TPGHGGATSSARKNR T285
S286-p
PGHGGAtssARKNRW
0 8
SF3B1 (human) PGHGGAtssARKNRW S286-p
SF3B1 (mouse) PGHGGAtssARKNRW S286-p
SF3B1 (rat) PGHGGATSSARKNRW S286
SF3B1 (cow) PGHGGATSSARKNRW S286
S287-p
GHGGAtssARKNRWD
0 31
SF3B1 (human) GHGGAtssARKNRWD S287-p
SF3B1 (mouse) GHGGAtssARKNRWD S287-p
SF3B1 (rat) GHGGATSSARKNRWD S287
SF3B1 (cow) GHGGATSSARKNRWD S287
T296-p
RKNRWDEtPKtERDt
0 114
SF3B1 (human) RKNRWDEtPKtERDt T296-p
SF3B1 (mouse) RKNRWDEtPKtERDt T296-p
SF3B1 (rat) RKNRWDEtPKTERDt T296-p
SF3B1 (cow) RKNRWDETPKTERDT T296
T299-p
RWDEtPKtERDtPGH
Upstream
0 97
Treatment
  • metastatic potential
SF3B1 (human) RWDEtPKtERDtPGH T299-p
SF3B1 (mouse) RWDEtPKtERDtPGH T299-p
SF3B1 (rat) RWDEtPKTERDtPGH T299
SF3B1 (cow) RWDETPKTERDTPGH T299
T303-p
tPKtERDtPGHGsGW
Upstream
0 118
Treatment
  • metastatic potential
SF3B1 (human) tPKtERDtPGHGsGW T303-p
SF3B1 (mouse) tPKtERDtPGHGsGW T303-p
SF3B1 (rat) tPKTERDtPGHGSGW T303-p
SF3B1 (cow) TPKTERDTPGHGSGW T303
S308-p
RDtPGHGsGWAEtPR
0 22
SF3B1 (human) RDtPGHGsGWAEtPR S308-p
SF3B1 (mouse) RDtPGHGsGWAEtPR S308-p
SF3B1 (rat) RDtPGHGSGWAEtPR S308
SF3B1 (cow) RDTPGHGSGWAETPR S308
T313-p
HGsGWAEtPRtDrGG
Upstream
Downstream
2 128
SF3B1 (human)
T313-p
SF3B1 (mouse)
T313-p
SF3B1 (rat)
T313-p
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • CDK2 (human)
Phosphatases, in vitro:
  • PPP1CA (human)
Putative upstream phosphatases:
  • PPP1CA (human)
Regulatory protein:
  • NIPP-1 (human)
Treatment
  • BI_4834
  • nocodazole
SF3B1 (human) HGsGWAEtPRtDrGG T313-p
SF3B1 (mouse) HGsGWAEtPRtDRGG T313-p
SF3B1 (rat) HGSGWAEtPRTDRGG T313-p
SF3B1 (cow) HGSGWAETPRTDRGG T313
T316-p
GWAEtPRtDrGGDsI
0 16
SF3B1 (human) GWAEtPRtDrGGDsI T316-p
SF3B1 (mouse) GWAEtPRtDRGGDsI T316-p
SF3B1 (rat) GWAEtPRTDRGGDsI T316
SF3B1 (cow) GWAETPRTDRGGDSI T316
R318-m1
AEtPRtDrGGDsIGE
0 1
SF3B1 (human) AEtPRtDrGGDsIGE R318-m1
SF3B1 (mouse) AEtPRtDRGGDsIGE R318
SF3B1 (rat) AEtPRTDRGGDsIGE R318
SF3B1 (cow) AETPRTDRGGDSIGE R318
S322-p
RtDrGGDsIGEtPtP
Upstream
0 10
Treatment
  • AZD1152
  • ZM447439
SF3B1 (human) RtDrGGDsIGEtPtP S322-p
SF3B1 (mouse) RtDRGGDsIGEtPtP S322-p
SF3B1 (rat) RTDRGGDsIGEtPtP S322-p
SF3B1 (cow) RTDRGGDSIGETPTP S322
T326-p
GGDsIGEtPtPGAsk
Upstream
0 59
Treatment
  • AZD1152
  • nocodazole
  • SB202190
  • U0126
  • ZM447439
SF3B1 (human) GGDsIGEtPtPGAsk T326-p
SF3B1 (mouse) GGDsIGEtPtPGAsk T326-p
SF3B1 (rat) GGDsIGEtPtPGAsK T326-p
SF3B1 (cow) GGDSIGETPTPGASK T326
T328-p
DsIGEtPtPGAskRK
Upstream
0 56
Treatment
  • AZD1152
  • ischemia
  • nocodazole
  • SB202190
  • U0126
  • ZM447439
SF3B1 (human) DsIGEtPtPGAskRK T328-p
SF3B1 (mouse) DsIGEtPtPGAskRK T328-p
SF3B1 (rat) DsIGEtPtPGAsKRN T328-p
SF3B1 (cow) DSIGETPTPGASKRK T328
S332-p
EtPtPGAskRKSRWD
Upstream
0 26
Treatment
  • BI2536
SF3B1 (human) EtPtPGAskRKSRWD S332-p
SF3B1 (mouse) EtPtPGAskRKSRWD S332-p
SF3B1 (rat) EtPtPGAsKRNFRWD S332-p
SF3B1 (cow) ETPTPGASKRKSRWD S332
K333-ac
tPtPGAskRKSRWDE
0 38
SF3B1 (human) tPtPGAskRKSRWDE K333-ac
SF3B1 (mouse) tPtPGAskRKSRWDE K333-ac
SF3B1 (rat) tPtPGAsKRNFRWDE K333
SF3B1 (cow) TPTPGASKRKSRWDE K333
K333-ub
tPtPGAskRKSRWDE
0 4
SF3B1 (human) tPtPGAskRKSRWDE K333-ub
SF3B1 (mouse) tPtPGAsKRKSRWDE K333
SF3B1 (rat) tPtPGAsKRNFRWDE K333
SF3B1 (cow) TPTPGASKRKSRWDE K333
T341-p
RKSRWDEtPAsQMGG
0 27
SF3B1 (human) RKSRWDEtPAsQMGG T341-p
SF3B1 (mouse) RKSRWDEtPAsQMGG T341-p
SF3B1 (rat) RNFRWDETPASQMGG T341
SF3B1 (cow) RKSRWDETPASQMGG T341
S344-p
RWDEtPAsQMGGstP
0 16
SF3B1 (human) RWDEtPAsQMGGstP S344-p
SF3B1 (mouse) RWDEtPAsQMGGstP S344-p
SF3B1 (rat) RWDETPASQMGGSTP S344
SF3B1 (cow) RWDETPASQMGGSTP S344
S349-p
PAsQMGGstPVLtPG
0 25
SF3B1 (human) PAsQMGGstPVLtPG S349-p
SF3B1 (mouse) PAsQMGGstPVLtPG S349-p
SF3B1 (rat) PASQMGGSTPVLTPG S349
SF3B1 (cow) PASQMGGSTPVLTPG S349
T350-p
AsQMGGstPVLtPGK
0 46
SF3B1 (human) AsQMGGstPVLtPGK T350-p
SF3B1 (mouse) AsQMGGstPVLtPGK T350-p
SF3B1 (rat) ASQMGGSTPVLTPGK T350
SF3B1 (cow) ASQMGGSTPVLTPGK T350
T354-p
GGstPVLtPGKTPIG
Upstream
1 18
Kinase, in vitro:
  • CDK2 (human)
Treatment
  • BI_4834
SF3B1 (human) GGstPVLtPGKTPIG T354-p
SF3B1 (mouse) GGstPVLtPGKTPIG T354-p
SF3B1 (rat) GGSTPVLTPGKTPIG T354
SF3B1 (cow) GGSTPVLTPGKTPIG T354
T362-p
PGKTPIGtPAMNMAt
0 3
SF3B1 (human) PGKTPIGtPAMNMAt T362-p
SF3B1 (mouse) PGKTPIGtPAMNMAT T362-p
SF3B1 (rat) PGKTPIGTPAMNMAT T362
SF3B1 (cow) PGKTPIGTPAMNMAT T362
T369-p
tPAMNMAtPtPGHIM
0 3
SF3B1 (human) tPAMNMAtPtPGHIM T369-p
SF3B1 (mouse) tPAMNMATPTPGHIM T369
SF3B1 (rat) TPAMNMATPTPGHIM T369
SF3B1 (cow) TPAMNMATPTPGHIM T369
T371-p
AMNMAtPtPGHIMsM
0 2
SF3B1 (human) AMNMAtPtPGHIMsM T371-p
SF3B1 (mouse) AMNMATPTPGHIMSM T371
SF3B1 (rat) AMNMATPTPGHIMSM T371
SF3B1 (cow) AMNMATPTPGHIMSM T371
S377-p
PtPGHIMsMtPEQLQ
0 1
SF3B1 (human) PtPGHIMsMtPEQLQ S377-p
SF3B1 (mouse) PTPGHIMSMTPEQLQ S377
SF3B1 (rat) PTPGHIMSMTPEQLQ S377
SF3B1 (cow) PTPGHIMSMTPEQLQ S377
T379-p
PGHIMsMtPEQLQAW
0 1
SF3B1 (human) PGHIMsMtPEQLQAW T379-p
SF3B1 (mouse) PGHIMSMTPEQLQAW T379
SF3B1 (rat) PGHIMSMTPEQLQAW T379
SF3B1 (cow) PGHIMSMTPEQLQAW T379
S400-p
DERNRPLsDEELDAM
0 17
SF3B1 (human) DERNRPLsDEELDAM S400-p
SF3B1 (mouse) DERNRPLsDEELDAM S400-p
SF3B1 (rat) DERNRPLFDEELDAM F400
SF3B1 (cow) DERNRPLSDEELDAM S400
K413-ub
AMFPEGYkVLPPPAG
0 1
SF3B1 (human) AMFPEGYkVLPPPAG K413-ub
SF3B1 (mouse) AMFPEGYKVLPPPAG K413
SF3B1 (rat) AMFPEGYKVLPPPAG K413
SF3B1 (cow) AMFPEGYKVLPPPAG K413
K413-sm
AMFPEGYkVLPPPAG
0 4
SF3B1 (human) AMFPEGYkVLPPPAG K413-sm
SF3B1 (mouse) AMFPEGYkVLPPPAG K413-sm
SF3B1 (rat) AMFPEGYKVLPPPAG K413
SF3B1 (cow) AMFPEGYKVLPPPAG K413
Y421-p
VLPPPAGyVPIRtPA
0 5
SF3B1 (human) VLPPPAGyVPIRtPA Y421-p
SF3B1 (mouse) VLPPPAGyVPIRtPA Y421-p
SF3B1 (rat) VLPPPAGYVPIRTPA Y421
SF3B1 (cow) VLPPPAGYVPIRTPA Y421
T426-p
AGyVPIRtPARkLtA
Upstream
1 34
Kinase, in vitro:
  • CDK2 (human)
Treatment
  • ischemia
  • LRRK2-IN-1
SF3B1 (human) AGyVPIRtPARkLtA T426-p
SF3B1 (mouse) AGyVPIRtPARKLtA T426-p
SF3B1 (rat) AGYVPIRTPARKLTA T426
SF3B1 (cow) AGYVPIRTPARKLTA T426
K430-ac
PIRtPARkLtAtPtP
0 1
SF3B1 (human) PIRtPARkLtAtPtP K430-ac
SF3B1 (mouse) PIRtPARKLtAtPtP K430
SF3B1 (rat) PIRTPARKLTATPTP K430
SF3B1 (cow) PIRTPARKLTATPTP K430
T432-p
RtPARkLtAtPtPLG
0 14
SF3B1 (human) RtPARkLtAtPtPLG T432-p
SF3B1 (mouse) RtPARKLtAtPtPLG T432-p
SF3B1 (rat) RTPARKLTATPTPLG T432
SF3B1 (cow) RTPARKLTATPTPLG T432
T434-p
PARkLtAtPtPLGGM
Upstream
3 29
Kinase, in vitro:
  • DYRK1A (human)
Putative in vivo kinases:
  • DYRK1A (human)
  • DYRK1B (human)
Treatment
  • AnnH75
  • harmine
  • ischemia
SF3B1 (human) PARkLtAtPtPLGGM T434-p
SF3B1 (mouse) PARKLtAtPtPLGGM T434-p
SF3B1 (rat) PARKLTATPTPLGGM T434
SF3B1 (cow) PARKLTATPTPLGGM T434
T436-p
RkLtAtPtPLGGMtG
Upstream
0 34
Treatment
  • ischemia
SF3B1 (human) RkLtAtPtPLGGMtG T436-p
SF3B1 (mouse) RKLtAtPtPLGGMTG T436-p
SF3B1 (rat) RKLTATPTPLGGMTG T436
SF3B1 (cow) RKLTATPTPLGGMTG T436
T442-p
PtPLGGMtGFHMQTE
0 3
SF3B1 (human) PtPLGGMtGFHMQTE T442-p
SF3B1 (mouse) PtPLGGMTGFHMQTE T442
SF3B1 (rat) PTPLGGMTGFHMQTE T442
SF3B1 (cow) PTPLGGMTGFHMQTE T442
K454-ub
QTEDRTMkSVNDQPS
0 2
SF3B1 (human) QTEDRTMkSVNDQPS K454-ub
SF3B1 (mouse) QTEDRTMKSVNDQPS K454
SF3B1 (rat) QTEDRTMKSVNDQPS K454
SF3B1 (cow) QTEDRTMKNVNDQPS K454
K468-ub
SGNLPFLkPDDIQyF
0 2
SF3B1 (human) SGNLPFLkPDDIQyF K468-ub
SF3B1 (mouse) SGNLPFLKPDDIQYF K468
SF3B1 (rat) SGNLPFLKPDDIQYF K468
SF3B1 (cow) SGNLPFLKPDDIQYF K468
K468-sm
SGNLPFLkPDDIQyF
0 1
SF3B1 (human) SGNLPFLkPDDIQyF K468-sm
SF3B1 (mouse) SGNLPFLKPDDIQYF K468
SF3B1 (rat) SGNLPFLKPDDIQYF K468
SF3B1 (cow) SGNLPFLKPDDIQYF K468
Y474-p
LkPDDIQyFDkLLVD
0 1
SF3B1 (human) LkPDDIQyFDkLLVD Y474-p
SF3B1 (mouse) LKPDDIQYFDKLLVD Y474
SF3B1 (rat) LKPDDIQYFDKLLVD Y474
SF3B1 (cow) LKPDDIQYFDKLLVD Y474
K477-ub
DDIQyFDkLLVDVDE
0 1
SF3B1 (human) DDIQyFDkLLVDVDE K477-ub
SF3B1 (mouse) DDIQYFDKLLVDVDE K477
SF3B1 (rat) DDIQYFDKLLVDVDE K477
SF3B1 (cow) DDIQYFDKLLVDVDE K477
S488-p
DVDESTLsPEEQkER
Upstream
0 24
Treatment
  • nocodazole